Home China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
 

Keywords :   


China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China

2013-08-25 10:18:37| Biotech - Topix.net

MicuRx Pharmaceuticals, a San Francisco-Shanghai antibiotics company, raised $25 million in Series B financing.

Tags: review big china accused

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.112
15.11
15.11 RIDE THE 92 23-24
15.11
15.114m×4m
15.11FG/AG 25.0
15.11
15.11Edwards
More »